ECMO et support cardio-circulatoire. [ECMO and cardiopulmonary support]

Détails

ID Serval
serval:BIB_0B2B343632B1
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
ECMO et support cardio-circulatoire. [ECMO and cardiopulmonary support]
Périodique
Revue Médicale de la Suisse Romande
Auteur(s)
Mueller  X. M., Tevaearai  H. T., Horisberger  J., Godar  G., von Segesser  L. K.
ISSN
0035-3655
Statut éditorial
Publié
Date de publication
03/2002
Volume
122
Numéro
3
Pages
127-30
Notes
English Abstract
Journal Article
Review --- Old month value: Mar
Résumé
ECMO (extracorporeal membrane oxygenation) may be viewed as a prolonged cardiopulmonary bypass allowing for a prolonged cardio-respiratory support. Since its introduction in the 60's, its indication has expanded from acute respiratory failure to acute cardiac failure refractory to conventional treatments. The target group involves mainly those patients presenting with a cardiogenic shock following cardiac surgery or acute myocardial infarction. The advantages of this form of circulatory support, when compared with long-term ventricular assist devices, are its less invasive aspect, its ease of implantation and its reduced cost. However, its main limitation lies in its limited duration of 7 to 10 days, in particular because of hemorrhage complications. Currently, ECMO provides a temporary hemodynamical stability in order to perform an invasive cardiac treatment (coronary bypass or percutaneous dilatation), or to assess the eligibility of the patient for a long-term ventricular assist device, which will enable to wait for the availability of an allograft. The latter scenario is crucial nowadays because of the severe lack of organ donors, which is the leading cause of death among patients waiting for a heart transplant.
Mots-clé
Cardiac Output, Low/*therapy Extracorporeal Membrane Oxygenation/adverse effects/*methods Humans Shock, Cardiogenic/*therapy
Pubmed
Création de la notice
14/02/2008 15:17
Dernière modification de la notice
20/08/2019 13:32
Données d'usage